Retrieved from Lund University's publications database
- Associations between macrophage colony-stimulating factor and monocyte chemotactic protein 1 in plasma and first-time coronary events : A Nested case-control Study
- Elevated CA125 is associated with incident heart failure and increased mortality in patients with acute coronary syndrome
- Influence of GSTM1, GSTT1 and GSTP1 gene polymorphisms on the appearance of microalbuminuria in type 2 diabetes mellitus patients
- A high quality diet is associated with reduced systemic inflammation in middle-aged individuals.
- Galectin 3 is a powerful risk predictor for recurrent coronary events in acute coronary syndrome patients
- High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events.
- Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.
- Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein.
- Plasma S100A8/A9 Correlates With Blood Neutrophil Counts, Traditional Risk Factors, and Cardiovascular Disease in Middle-Aged Healthy Individuals.
- Ly-6C(hi) monocytes: a potential target for preventing transplant arteriosclerosis?
- Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based study.
- S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease.
- Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease
- Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events.
- Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.
- Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease.
- Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.